2.7134
price down icon1.99%   -0.0566
 
loading

Akebia Therapeutics Inc Azioni (AKBA) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
8.96%
62.47
57.34 46.50 37.43 43.65
Cost Of Revenue
30.09%
9.919
7.625 20.36 14.16 17.05
Gross Profit
5.72%
52.55
49.71 26.13 23.27 26.60
Operating Expenses
6.26%
38.46
36.20 40.44 35.77 35.33
Benefits Costs and Expenses
21.48%
62.23
51.22 69.30 57.47 52.23
Costs And Expenses
21.48%
62.23
51.22 69.30 57.47 52.23
Operating Income/Loss
4.25%
14.09
13.51 -14.31 -12.51 -8.725
Income/Loss From Continuing Operations Before Tax
95.96%
0.247
6.112 -22.80 -20.04 -8.582
Income/Loss From Continuing Operations After Tax
95.96%
0.247
6.112 -22.80 -20.04 -8.582
Net Income/Loss
95.96%
0.247
6.112 -22.80 -20.04 -8.582
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
11.49%
262.57
235.50 2.603 210.35 209.71
Diluted Average Shares
12.21%
271.10
241.60 2.603 210.35 209.71
Basic Earnings Per Share
100.00%
-
0.03 -0.11 -0.10 -0.04
Diluted Earnings Per Share
100.00%
-
0.03 -0.11 -0.10 -0.04
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.68
price down icon 0.24%
$9.5101
price down icon 2.01%
$53.40
price up icon 0.49%
drug_manufacturers_specialty_generic RDY
$14.16
price down icon 1.94%
$141.22
price down icon 3.76%
$426.54
price down icon 3.08%
Capitalizzazione:     |  Volume (24 ore):